Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders
Public ClinicalTrials.gov record NCT01706523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Extension Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of STX209 (Arbaclofen) in Subjects With Autism Spectrum Disorders
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label extension protocol that will provide necessary data on the safety, tolerability, pharmacokinetics and efficacy of STX209 among subjects with ASD.
Study identification
- NCT ID
- NCT01706523
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 5 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2011 (Type not available)
- Primary completion
- Jul 2013 (Actual)
- Completion
- Jul 2013 (Estimated)
- Last update posted
- Jul 31, 2013
2011 – 2013
United States locations
- U.S. sites
- 25
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Autism Research & Resource Center | Phoenix | Arizona | 85006 | — |
| University of California-Los Angeles Neuropsychiatric Institute | Los Angeles | California | 90024 | — |
| UCDavis M.I.N.D Insitute | Sacramento | California | 95817 | — |
| Pharmax Research Clinic | Miami | Florida | 33126 | — |
| Lake Mary Pediatrics | Orange City | Florida | 32763 | — |
| Institute for Behavioral Medicine | Smyrna | Georgia | 30080 | — |
| Institute for Juvenile Research | Chicago | Illinois | 60608 | — |
| Riley Hospital for Children | Indianapolis | Indiana | 46202 | — |
| Kennedy Krieger Institute | Baltimore | Maryland | 21205 | — |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | — |
| University of Massachusetts | Worcester | Massachusetts | 01605 | — |
| University of Missouri, Thompson Research Center for Autism & Neurodevelopmental Disorders | Columbia | Missouri | 65211 | — |
| Seaver Autism Center, Mount Sinai Medical Center | New York | New York | 10029 | — |
| NYS Institute for Basic Research in Developmental Disabilities | Staten Island | New York | 10314 | — |
| UNC Chapel Hill Department of Psychiatry | Chapel Hill | North Carolina | 27514 | — |
| Akron Children's Hospital | Akron | Ohio | 44308 | — |
| Cutting Edge Research | Oklahoma City | Oklahoma | 73116 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| Suburban Research Associates | Media | Pennsylvania | 19063 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| University of Tennessee Medical Group, LeBonheur Children's Hospital | Memphis | Tennessee | 38103 | — |
| Vanderbilt Kennedy Center | Nashville | Tennessee | 37203 | — |
| Red Oaks Psychiatry Associates, P.A. | Houston | Texas | 77090 | — |
| Road Runner Research | San Antonio | Texas | 78258 | — |
| Seattle Children's Hospital | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01706523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01706523 live on ClinicalTrials.gov.